Patent: 8,084,580
✉ Email this page to a colleague
Summary for Patent: 8,084,580
| Title: | Therapeutic human albumin solutions with low prekallikrein activator (PKA) activity and process for obtaining them |
| Abstract: | The invention discloses a purified albumin solution of human origin with low prekallicrein activator (PKA) activity and stability over time characterized in that it has an antithrombin content equal to or greater than 0.03 mg/g of albumin, and a process for production thereof by the partial extraction of the antithrombin during fractionation of the human plasma. |
| Inventor(s): | Juan Ignacio Jorquera Nieto, Nuria Hosta Mateu, Olga Santaeularia Lozano |
| Assignee: | Grifols SA |
| Application Number: | US11/689,028 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,084,580
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Kedrion, S.p.a. | KEDBUMIN | albumin (human) | Injection | 125384 | June 03, 2011 | ⤷ Start Trial | 2027-03-21 |
| Kedrion Biopharma Inc. | KEDBUMIN | albumin (human) | Injection | 125384 | 3-Jun-11 | ⤷ Start Trial | 2027-03-21 |
| Kedrion, S.p.a. | KEDBUMIN | albumin (human) | Injection | 125384 | September 05, 2013 | ⤷ Start Trial | 2027-03-21 |
| Kedrion Biopharma Inc. | KEDBUMIN | albumin (human) | Injection | 125384 | 5-Sep-13 | ⤷ Start Trial | 2027-03-21 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 8,084,580
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2005202654 | ⤷ Start Trial |
| Brazil | PI0502744 | ⤷ Start Trial |
| Germany | 602005003426 | ⤷ Start Trial |
| European Patent Office | 1656954 | ⤷ Start Trial |
| Spain | 2221817 | ⤷ Start Trial |
| Spain | 2294664 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
